Replies to post #139023 on NorthWest Biotherapeutics Inc (NWBO)

[pgsd]

Again correct me if I am wrong but this would require some degree of fraudulent action taken by the company which there is no evidence and lacks credibility. Any failure of endpoints in addition to having to report these failures to the FDA, the company would have to advise investors of under sec regulations. The company (essentially lawyers) are very well aware of their legal obligations. It is therefore ludicrous to suggest they would risk their personal wealth in this manner.

[hankmanhub]

Ex, CVN was a safety concern, not a futility concern - not at all comparable. Furthermore, any futility recommendation at an IA is only for internal info and the co can decide on its own whether to continue or not. So far as I know, on a futility rec, there is no requirement for any consultation with the FDA on how to proceed nor is there any actual indication that any such meeting ever actually happened SFAIK. The trial simply proceeds as per the protocols. The meeting is mere speculation with no reason to have it. You know the saying "If you ask the answer will be NO!"